NEW YORK, Feb. 11 (GenomeWeb News) - Affymetrix and the Translational Genomics Research Institute of Phoenix, Ariz., today announced a non-exclusive agreement where TGEN genotyping services to its collaborators and NIH-funded core facility programs using Affymetrix's DNA analysis technology.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.